Clindamycin Hydrochloride (CAS 21462-39-5) is a lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic bacteria and certain Gram-positive aerobes. It is particularly important in bone and joint infections, intra-abdominal infections, gynecological infections and skin/soft tissue infections, especially when alternative agents are unsuitable.
At TCS INDUSTRIES LIMITED,
is supplied as a high-quality API appropriate for oral capsules, injectable formulations and topical products (such as gels and lotions used in acne therapy). The API is supported by detailed impurity profiles and process controls, helping customers meet global regulatory expectations.
Clindamycin is often considered alongside other antibiotics when designing a balanced infectious-disease portfolio. Within the same site, you can find:
- Clarithromycin 81103-11-9 – a macrolide antibiotic frequently used in respiratory and H. pylori regimens.
- Chloramphenicol 56-75-7 – a broad-spectrum agent used in topical and ophthalmic formulations and selected systemic indications.
- The wider API and excipient offering is accessible from the main Products page.
Formulation of clindamycin HCl must carefully consider solubility, taste, and route of administration. Oral capsules typically rely on robust fillers and lubricants for consistent content uniformity, while injectable products require strict control of pH, osmolarity and sterilization. For topical gels and solutions, developers aim for stable, non-irritating vehicles that deliver effective concentrations to the site of infection with good cosmetic acceptability.
Thanks to TCS GROUP’s experience with antibacterial APIs and excipients, customers benefit from reliable supply and technical support throughout development and scale-up. Clindamycin HCl from TCS INDUSTRIES LIMITED provides a strong foundation for hospital, dermatological and community infection-control portfolios.